Improving vancomycin prescribing and monitoring with staff education and support

Cameron Phillips; H Doan; S Quinn; C Kirkpatrick; D Gordon; M Doogue

Improving vancomycin prescribing and monitoring with staff education and support

Cameron Phillips, H Doan, S Quinn, C Kirkpatrick, D Gordon, M Doogue

Research output: Contribution to conference › Abstract › peer-review

Abstract

Vancomycin is the antibiotic of choice for serious methicillin resistant Staphylococcus aureus (MRSA) infections. Low vancomycin concentrations increase the risk of therapeutic failure and drug resistance, whereas high concentrations increase the risk of drug toxicity. Low vancomycin concentrations have been associated with the emergence of Heteroogenous Vancomycin Intermediate S. Aureus (hVISA).

Original language	English
Pages	50
Number of pages	1
Publication status	Published - 2012
Event	Antimicrobials 2012: Australian Society of Antimicrobials - Brisbane, Australia Duration: 23 Feb 2012 → 25 Feb 2012 Conference number: 13

Conference

Conference	Antimicrobials 2012
Country/Territory	Australia
City	Brisbane
Period	23/02/12 → 25/02/12

Cite this

@conference{c44eebc30ae34ff9ad9e4188ca06c3a3,

title = "Improving vancomycin prescribing and monitoring with staff education and support",

abstract = "Vancomycin is the antibiotic of choice for serious methicillin resistant Staphylococcus aureus (MRSA) infections. Low vancomycin concentrations increase the risk of therapeutic failure and drug resistance, whereas high concentrations increase the risk of drug toxicity. Low vancomycin concentrations have been associated with the emergence of Heteroogenous Vancomycin Intermediate S. Aureus (hVISA).",

author = "Cameron Phillips and H Doan and S Quinn and C Kirkpatrick and D Gordon and M Doogue",

year = "2012",

language = "English",

pages = "50",

note = "Antimicrobials 2012 : Australian Society of Antimicrobials ; Conference date: 23-02-2012 Through 25-02-2012",

}

TY - CONF

T1 - Improving vancomycin prescribing and monitoring with staff education and support

AU - Phillips, Cameron

AU - Doan, H

AU - Quinn, S

AU - Kirkpatrick, C

AU - Gordon, D

AU - Doogue, M

N1 - Conference code: 13

PY - 2012

Y1 - 2012

N2 - Vancomycin is the antibiotic of choice for serious methicillin resistant Staphylococcus aureus (MRSA) infections. Low vancomycin concentrations increase the risk of therapeutic failure and drug resistance, whereas high concentrations increase the risk of drug toxicity. Low vancomycin concentrations have been associated with the emergence of Heteroogenous Vancomycin Intermediate S. Aureus (hVISA).

AB - Vancomycin is the antibiotic of choice for serious methicillin resistant Staphylococcus aureus (MRSA) infections. Low vancomycin concentrations increase the risk of therapeutic failure and drug resistance, whereas high concentrations increase the risk of drug toxicity. Low vancomycin concentrations have been associated with the emergence of Heteroogenous Vancomycin Intermediate S. Aureus (hVISA).

M3 - Abstract

SP - 50

T2 - Antimicrobials 2012

Y2 - 23 February 2012 through 25 February 2012

ER -

Improving vancomycin prescribing and monitoring with staff education and support

Abstract

Conference

Fingerprint

Cite this